BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20973318)

  • 1. Prognostic factors for survival in colorectal cancer patients.
    Laohavinij S; Maneechavakajorn J; Techatanol P
    J Med Assoc Thai; 2010 Oct; 93(10):1156-66. PubMed ID: 20973318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early discontinuation but not the timing of adjuvant therapy affects survival of patients with high-risk colorectal cancer: a population-based study.
    Ahmed S; Ahmad I; Zhu T; Arnold FP; Faiz Anan G; Sami A; Yadav SK; Alvi R; Haider K
    Dis Colon Rectum; 2010 Oct; 53(10):1432-8. PubMed ID: 20847626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, therapy and prognosis of colorectal cancer in different age groups. A population-based cohort study of the Rostock Cancer Registry.
    Fietkau R; Zettl H; Klöcking S; Kundt G
    Strahlenther Onkol; 2004 Aug; 180(8):478-87. PubMed ID: 15292968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
    Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
    Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are survival rates different for young and older patients with rectal cancer?
    O'Connell JB; Maggard MA; Liu JH; Etzioni DA; Ko CY
    Dis Colon Rectum; 2004 Dec; 47(12):2064-9. PubMed ID: 15657655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of combined therapy in pancreatic cancer with a poor prognosis: analysis of 233 clinical cases].
    Wang Y; Zhao P; Wang CF; Shan Y; Zhao DB; Tian YT; Sun YM; Che X; Zhang JW
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2381-5. PubMed ID: 20137689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
    Chan AK; Wong A; Jenken D; Heine J; Buie D; Johnson D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):665-77. PubMed ID: 15708244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for patients with colon or rectal carcinoma treated with resection only. Five-year follow-up report.
    Tominaga T; Sakabe T; Koyama Y; Hamano K; Yasutomi M; Takahashi T; Kodaira S; Kato T; Ogawa N
    Cancer; 1996 Aug; 78(3):403-8. PubMed ID: 8697383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
    Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
    Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
    Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of anterior resection for stage II rectal cancer without radiation: the role of adjuvant chemotherapy.
    Law WL; Ho JW; Chan R; Au G; Chu KW
    Dis Colon Rectum; 2005 Feb; 48(2):218-26. PubMed ID: 15711860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.
    Suárez J; Vera R; Balén E; Gómez M; Arias F; Lera JM; Herrera J; Zazpe C
    Colorectal Dis; 2008 Jul; 10(6):563-8. PubMed ID: 18070184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
    Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S
    Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of perineural invasion in patients with stage II colorectal cancer.
    Huh JW; Kim HR; Kim YJ
    Ann Surg Oncol; 2010 Aug; 17(8):2066-72. PubMed ID: 20182809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multivariate analysis of prognostic factors in colorectal cancer patients with different ages].
    Cai SR; Zheng S; Zhang SZ
    Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):483-5. PubMed ID: 16188146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
    Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
    J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
    Unsal D; Akyurek N; Uner A; Erpolat OP; Han U; Akmansu M; Mentes BB; Dursun A
    Am J Clin Oncol; 2008 Feb; 31(1):55-63. PubMed ID: 18376229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic analysis of 220 colorectal cancer patients with synchronous liver metastases].
    He YF; Li YH; Zhang DS; Xiang XJ; Xu RH; Pan ZZ; Zhou ZW; Jiang WQ; He YJ; Wan DS
    Ai Zheng; 2006 Sep; 25(9):1153-7. PubMed ID: 16965661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and disease outcome of UICC stages I-III colorectal cancer patients at Siriraj Hospital.
    Techawathanawanna S; Nimmannit A; Akewanlop C
    J Med Assoc Thai; 2012 Feb; 95 Suppl 2():S189-98. PubMed ID: 22574549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer invasion to Auerbach's plexus is an important prognostic factor in patients with pT3-pT4 colorectal cancer.
    Fujita S; Nakanisi Y; Taniguchi H; Yamamoto S; Akasu T; Moriya Y; Shimoda T
    Dis Colon Rectum; 2007 Nov; 50(11):1860-6. PubMed ID: 17899273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.